Indaptus Therapeutics Inc (INDP)
2.25
-0.07
(-3.02%)
USD |
NASDAQ |
Jun 21, 16:00
Indaptus Therapeutics Total Liabilities (Quarterly): 1.588M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.588M |
| December 31, 2023 | 2.847M |
| September 30, 2023 | 2.460M |
| June 30, 2023 | 2.219M |
| March 31, 2023 | 1.959M |
| December 31, 2022 | 3.433M |
| September 30, 2022 | 2.886M |
| Date | Value |
|---|---|
| June 30, 2022 | 3.652M |
| March 31, 2022 | 3.730M |
| December 31, 2021 | 4.677M |
| September 30, 2021 | 5.780M |
| June 30, 2021 | 6.156M |
| December 31, 2020 | 2.016M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.588M
Minimum
Mar 2024
6.156M
Maximum
Jun 2021
3.339M
Average
2.886M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| Oragenics Inc | 0.9087M |
| Rezolute Inc | 16.88M |
| GT Biopharma Inc | 4.60M |
| IGM Biosciences Inc | 214.88M |
| 180 Life Sciences Corp | 4.396M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.95M |
| Shareholders Equity (Quarterly) | 9.361M |